Support more types of study-centric analyses
Owner: Rebecka Hall
What business value does this epic create? / Which problem is this epic trying to solve?
Strategic fit
Link to strategy: GOAL 1 Streamlining production of reviews and simplifying editorial systems and processes
Future of review production project: New review format
Hypothesis
- Supporting more types of analyses in study-centric data will reduce number of custom input analyses in Cochrane reviews
- Enabling re-use of data e.g. for labels will improve submission quality and reduce cost of copy editing
- Structured subgrouping and sensitivity analyses using covariates will improve decision making for analyses
Success metric
Proportion of study-centric analyses/total number of analyses per review (for reviews started 2023) by end of 2023 is above 0.8.
Which assumptions are made in relation to the value?
- Although, not a majority of analyses would need these features, it is a conisderable number that would
What are the dependencies for fulfilling the business value?
- Prioritization by review development team, see MURAL for data collection and description of use cases.
- Author training and guidance
- Mockups and requirements for implementation
- Test data
What are the risks related to this roadmap item?
What is included in the scope of this solution?
At least:
- Outcome grouping
- Subgroup by intervention
- Subgroup by outcome
- Filer by intervention
- Filter by outcome